Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. - Wikidata - wikimedia - TriplyDB

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy.

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy.

http://www.wikidata.org/entity/Q42739866

about

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets Spinal muscular atrophy: from tissue specificity to therapeutic strategies Cervical Spinal Cord Atrophy Profile in Adult SMN1-Linked SMA Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy.Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy.Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy.Advances in understanding the role of disease-associated proteins in spinal muscular atrophy.New insights into SMA pathogenesis: immune dysfunction and neuroinflammation.DNA Damage Response and DNA Repair in Skeletal Myocytes From a Mouse Model of Spinal Muscular Atrophy.Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy.miRNA in spinal muscular atrophy pathogenesis and therapy.Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy.[Spinal muscular atrophy : Time for newborn screening?]Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy.Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice.Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice

P2860

Q26774987-51E7AC08-16B3-479D-92F2-80054DE507E3 Q33614675-9C7DD217-3D02-4824-9701-B30FB99667A9 Q33830937-F4AE90EB-5A38-4D0A-87D8-D699DA2CFD00 Q34103656-C1541F73-3732-40BB-A4B5-1390ED010ED0 Q35029616-683B22D4-8FA8-404C-A61B-A5CAAC358413 Q35992632-B37690C3-8008-4111-9624-3AFD178314BB Q36142393-C7D9F254-3B40-4A2D-855E-3DEE467747BE Q36199822-84109DF7-E57D-48E0-868B-1740ED9C8F5B Q36205773-8EC8305E-94E6-47AE-A581-32B27A6AA508 Q36484406-1E92929C-FEA3-4DFB-B9A7-6D3AC168973B Q37094802-356151FA-3BCA-4BA8-AB2F-CEB6F1226355 Q37238936-CDBB7D6C-5C43-471A-9D6E-88AADF8ACC60 Q37255468-0B10C036-BB11-487C-85CC-FEDE3678A046 Q38668630-0329A242-C7CE-4C74-934E-13F9CE9C1A14 Q40140411-3DAC2371-61C4-4B39-B673-822798A76BC4 Q41042700-6CAF65C8-464C-4B8A-B9D5-BE7E0CE24447 Q41857431-5FD0CFF4-1596-4D60-A6AC-B10A85855095 Q47379842-F23DBC70-7DFB-4DDF-B7CC-1DFB53AB539B Q49389328-8B134E3E-2D4D-48D7-822B-185F574BC8CF Q50172108-AE1D72ED-C844-4AAF-8323-0AE8D1D14638 Q51204048-CDA44D8D-5AA1-41F4-AB5F-D3F3E483F9A2 Q55369340-0D9B19EC-D6CF-416A-A7D6-F3EA2C354923 Q57463072-ED6DC8E1-B601-442C-9877-E624F7687D73

P2860

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy.

http://www.wikidata.org/entity/Q42739866

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@en

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@nl

type

label

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@en

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@nl

prefLabel

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@en

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@nl

P1433

Q42739866-738B33C1-FC1E-403E-A556-056B06548A3A

P1476

Q42739866-48CBFF38-4961-408A-9CE0-0490A476683D

P2093

Q42739866-127789E0-D42B-4B46-9BAF-9C2DF18F93EF

Q42739866-40CC82D6-EE78-44CB-9399-4A33D8B4F649

Q42739866-67A9F678-213C-49AC-8485-52ACDB6B8E63

Q42739866-E3FF6EA3-A751-4BED-A76D-7B35275B64F8

Q42739866-F79FD36F-B6CB-4348-BF7D-722853E09242

Q42739866-FD00C273-40D1-470A-A019-271322842C2B

P2860

Q42739866-0689D559-9F5E-4D82-A212-D425DF2A4A02

Q42739866-0CF238D8-0508-43C3-828E-5A1CD972D0BD

Q42739866-0E56F1F1-F0AD-4C6D-9D09-14AE47CBFE78

Q42739866-160180BD-50E3-4503-A344-8E958F509170

Q42739866-27B7AAD1-4328-436C-B01B-5EC6F3A3DFB0

Q42739866-3155E3F4-BBBD-4BC1-B1DF-FE349BB29C32

Q42739866-376DE4FB-AED8-4267-918B-12A221B4F855

Q42739866-3A270445-2ECD-44D3-9B1B-19F57F4BDE51

Q42739866-4729B20D-3B5B-4A77-952D-C41616CF8F48

Q42739866-47FA42C7-D5D0-4D9E-96B9-76A6405BF930

P304

Q42739866-583955B5-984F-4167-8628-9E67AB7913A7

P31

Q42739866-FF6693CC-D819-4749-94BA-4AC08F2405CC

P356

Q42739866-5B9C8684-6D99-41C8-ABB4-8C07BA34124B

P433

Q42739866-F7F71E34-C40A-4E52-918F-948E63DF575C

P478

Q42739866-F23BECD5-A4E5-4A19-9C35-4513628A7202

P50

Q42739866-B4F6E54B-83FC-4BE9-B781-8DFA37CDF1D7

Q42739866-C8FE3840-118E-4B91-B988-2A2980E7781A

P577

Q42739866-2B85619F-F959-45A6-8AA9-E0ED45306D23

P5875

Q42739866-74EA57AC-6220-493B-8D04-A02D7CE8223A

P698

Q42739866-667F2479-FCE7-4C11-9B26-467FFE486A73

P921

Q42739866-6C6CE6E4-98FC-48B0-B3EB-5655F2C82D57

P932

Q42739866-F160C712-0C35-494A-8FD1-5507503188CC

P356

P1433

Human Molecular Genetics

P1476

Myogenic program dysregulation ...... is in spinal muscular atrophy.

@en

P2093

Armin Yazdani

http://www.w3.org/2001/XMLSchema#string

Céline Boudreau-Larivière

http://www.w3.org/2001/XMLSchema#string

Justin G Boyer

http://www.w3.org/2001/XMLSchema#string

Lyndsay M Murray

http://www.w3.org/2001/XMLSchema#string

Marc-Olivier Deguise

http://www.w3.org/2001/XMLSchema#string

Yves De Repentigny

http://www.w3.org/2001/XMLSchema#string

P2860

Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.

Hearts of dystonia musculorum mice display normal morphological and histological features but show signs of cardiac stress

Pax7 is required for the specification of myogenic satellite cells

Identification and characterization of a spinal muscular atrophy-determining gene

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late

Building muscle: molecular regulation of myogenesis.

Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons

Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy

P304

4249-4259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU142

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Céline Boudreau-Larivière

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261292712

http://www.w3.org/2001/XMLSchema#string

P698

24691550

http://www.w3.org/2001/XMLSchema#string

P921

spinal muscular atrophy

P932

4103674

http://www.w3.org/2001/XMLSchema#string